USANA HEALTH SCIENCES, INC. (USNA) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
32/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinUSNA / S&P 22.21% / 15.20% |
LoseUSNA / S&P 1.57% / 15.00% |
LoseUSNA / S&P -166.67% / 50.40% |
| 2026-Q10/3 |
LoseUSNA / S&P -11.00% / -4.33% |
LoseUSNA / S&P 5.67% / 11.30% |
LoseUSNA / S&P -73.63% / 27.70% |
| 2025-Q40/3 |
LoseUSNA / S&P -28.75% / 2.65% |
LoseUSNA / S&P 8.28% / 9.00% |
LoseUSNA / S&P -74.43% / 13.40% |
| 2025-Q31/3 |
LoseUSNA / S&P -9.76% / 8.12% |
WinUSNA / S&P 5.88% / 4.61% |
LoseUSNA / S&P -68.90% / 13.45% |
| 2025-Q21/3 |
WinUSNA / S&P 13.20% / 10.94% |
LoseUSNA / S&P 2.75% / 4.83% |
LoseUSNA / S&P -37.06% / 10.63% |
| 2025-Q10/3 |
LoseUSNA / S&P -24.85% / -4.27% |
LoseUSNA / S&P -2.69% / 4.98% |
LoseUSNA / S&P -43.30% / 10.57% |
| 2024-Q40/3 |
LoseUSNA / S&P -5.35% / 2.41% |
LoseUSNA / S&P -7.22% / 5.25% |
LoseUSNA / S&P -33.64% / 6.15% |
| 2024-Q30/3 |
LoseUSNA / S&P -16.18% / 5.89% |
LoseUSNA / S&P -7.10% / 5.89% |
LoseUSNA / S&P -8.41% / 6.11% |
| 2024-Q20/3 |
LoseUSNA / S&P -6.72% / 4.28% |
LoseUSNA / S&P -7.67% / 5.38% |
LoseUSNA / S&P -12.80% / 5.12% |
| 2024-Q10/3 |
LoseUSNA / S&P -9.51% / 10.56% |
LoseUSNA / S&P -7.56% / 5.71% |
LoseUSNA / S&P -5.31% / 5.59% |
| 2023-Q40/3 |
LoseUSNA / S&P -8.55% / 11.69% |
LoseUSNA / S&P -7.77% / 6.81% |
LoseUSNA / S&P -8.08% / 7.78% |
| 2023-Q30/3 |
LoseUSNA / S&P -7.03% / -3.27% |
LoseUSNA / S&P -10.60% / 7.52% |
LoseUSNA / S&P -22.36% / -5.03% |
| 2023-Q20/3 |
LoseUSNA / S&P 0.22% / 8.74% |
LoseUSNA / S&P -12.16% / 9.50% |
LoseUSNA / S&P -28.07% / -8.57% |
| 2023-Q11/3 |
WinUSNA / S&P 18.23% / 7.50% |
LoseUSNA / S&P -15.40% / 10.77% |
LoseUSNA / S&P -37.57% / -15.69% |
| 2022-Q40/3 |
LoseUSNA / S&P -5.08% / 7.56% |
LoseUSNA / S&P -15.83% / 11.88% |
LoseUSNA / S&P -37.35% / -17.99% |
| 2022-Q30/3 |
LoseUSNA / S&P -22.54% / -4.88% |
LoseUSNA / S&P -15.59% / 13.47% |
LoseUSNA / S&P -39.14% / -1.41% |
| 2022-Q21/3 |
WinUSNA / S&P -8.92% / -16.10% |
LoseUSNA / S&P -13.95% / 13.71% |
LoseUSNA / S&P -31.12% / 11.04% |
| 2022-Q10/3 |
LoseUSNA / S&P -21.49% / -4.60% |
LoseUSNA / S&P -2.10% / 15.97% |
LoseUSNA / S&P -10.54% / 42.23% |
| 2021-Q40/3 |
LoseUSNA / S&P 9.76% / 11.03% |
LoseUSNA / S&P 4.57% / 15.00% |
LoseUSNA / S&P -2.05% / 96.40% |
| 2021-Q31/3 |
LoseUSNA / S&P -9.99% / 0.58% |
WinUSNA / S&P 12.26% / 10.77% |
LoseUSNA / S&P 21.34% / 69.42% |
| 2021-Q21/3 |
LoseUSNA / S&P 4.95% / 8.55% |
WinUSNA / S&P 18.57% / 6.58% |
LoseUSNA / S&P 31.35% / 51.81% |
| 2021-Q13/3 |
WinUSNA / S&P 26.59% / 6.17% |
WinUSNA / S&P 11.52% / -1.06% |
WinUSNA / S&P 31.10% / 7.39% |
| 2020-Q42/3 |
LoseUSNA / S&P 4.68% / 12.15% |
WinUSNA / S&P 6.95% / -3.72% |
WinUSNA / S&P 32.65% / -33.42% |
| 2020-Q32/3 |
LoseUSNA / S&P 0.30% / 8.93% |
WinUSNA / S&P 0.62% / -2.04% |
WinUSNA / S&P 24.48% / -27.10% |
| 2020-Q22/3 |
WinUSNA / S&P 27.13% / 20.54% |
LoseUSNA / S&P -5.98% / -0.46% |
WinUSNA / S&P 12.50% / -27.11% |
| 2020-Q11/3 |
LoseUSNA / S&P -26.47% / -19.60% |
LoseUSNA / S&P -9.89% / 3.47% |
WinUSNA / S&P -6.09% / -14.75% |
| 2019-Q41/3 |
WinUSNA / S&P 14.86% / 9.07% |
LoseUSNA / S&P -10.79% / 5.36% |
LoseUSNA / S&P -13.70% / 2.99% |
| 2019-Q31/3 |
LoseUSNA / S&P -13.90% / 1.70% |
LoseUSNA / S&P -6.42% / 5.02% |
WinUSNA / S&P 21.29% / 0.21% |
| 2019-Q21/3 |
LoseUSNA / S&P -5.29% / 4.30% |
LoseUSNA / S&P -0.31% / 6.64% |
WinUSNA / S&P 35.76% / 8.65% |
| 2019-Q11/3 |
LoseUSNA / S&P -28.76% / 13.65% |
LoseUSNA / S&P 7.96% / 8.12% |
WinUSNA / S&P 71.78% / 14.29% |
| 2018-Q42/3 |
WinUSNA / S&P -2.34% / -13.52% |
LoseUSNA / S&P USNA unavailable / 9.05% |
WinUSNA / S&P 101.18% / 18.23% |
| 2018-Q30/3 |
LoseUSNA / S&P 4.55% / 7.71% |
LoseUSNA / S&P USNA unavailable / 10.21% |
LoseUSNA / S&P -1.65% / 19.06% |
| 2018-Q21/3 |
WinUSNA / S&P 34.23% / 3.43% |
LoseUSNA / S&P USNA unavailable / 9.03% |
LoseUSNA / S&P -14.51% / 14.46% |
| 2018-Q11/3 |
WinUSNA / S&P 16.00% / -0.76% |
LoseUSNA / S&P USNA unavailable / 7.68% |
LoseUSNA / S&P -27.53% / 12.46% |
| 2017-Q41/3 |
WinUSNA / S&P 28.34% / 6.64% |
LoseUSNA / S&P USNA unavailable / 7.03% |
LoseUSNA / S&P -36.34% / 13.82% |
| 2017-Q31/3 |
LoseUSNA / S&P -9.98% / 4.48% |
LoseUSNA / S&P USNA unavailable / 5.68% |
WinUSNA / S&P 166.91% / 17.57% |
| 2017-Q22/3 |
WinUSNA / S&P 11.28% / 3.09% |
LoseUSNA / S&P USNA unavailable / 4.83% |
WinUSNA / S&P 85.58% / 17.74% |
| 2017-Q11/3 |
LoseUSNA / S&P -5.88% / 6.07% |
LoseUSNA / S&P USNA unavailable / 3.67% |
WinUSNA / S&P 33.33% / 13.32% |
| 2016-Q41/3 |
LoseUSNA / S&P -11.53% / 3.82% |
LoseUSNA / S&P USNA unavailable / 2.09% |
WinUSNA / S&P 11.45% / 7.05% |
| 2016-Q31/3 |
WinUSNA / S&P 24.16% / 3.85% |
LoseUSNA / S&P USNA unavailable / 0.20% |
LoseUSNA / S&P -67.46% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | USNA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -55.81% | 20.78% |
| Annualized return | -55.81% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | USNA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -85.56% | 83.14% |
| Annualized return | -32.10% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | USNA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -79.32% | 319.30% |
| Annualized return | -14.58% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |